Company Famimed Srl with Fiscal Code 15513101
recorded a turnover of 2024 of
121.217,
with a net profit of
75.385
and having an average number of employees of
4.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Famimed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
43.122
45.574
44.332
52.520
64.633
68.633
75.402
80.767
99.015
121.217
Total Income - EUR
43.146
45.591
44.332
52.520
64.633
70.701
75.409
81.782
99.063
121.225
Total Expenses - EUR
16.740
15.789
18.248
24.191
21.537
23.976
23.436
23.949
29.541
42.204
Gross Profit/Loss - EUR
26.406
29.802
26.084
28.329
43.096
46.726
51.973
57.832
69.522
79.021
Net Profit/Loss - EUR
25.112
29.346
25.612
27.804
42.449
46.270
51.219
57.025
68.532
75.385
Employees
3
3
3
4
2
3
3
3
3
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 23.1%, from 99.015 euro in the year 2023, to 121.217 euro in 2024.
The Net Profit increased by 7.236 euro, from 68.532 euro in 2023, to 75.385 in the last year.
Check the financial reports for the company - Famimed Srl
Financial Rating - FAMIMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Famimed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Famimed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Famimed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
81.161 euro in 2024 which includes Inventories of
119 euro, Receivables of
80.724 euro and cash availability of
319 euro.
The company's Equity was valued at
83.980 euro, while total Liabilities amounted to
2.582 euro.
Equity increased by 8.167 euro, from 76.239 euro in 2023, to 83.980 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Famimed Srl